Volume 40; Issue 20

Oncology Times

Volume 40; Issue 20
1

Cervical Cancer Screening

Year:
2018
Language:
english
File:
PDF, 15.39 MB
english, 2018
2

Ovarian Cancer

Year:
2018
File:
PDF, 15.24 MB
2018
3

LOXO-292 Durability Update in Patients With RET Fusion-Positive NSCLC

Year:
2018
File:
PDF, 15.31 MB
2018
5

Novel Biomarker in Ovarian Cancer Patients Predicts Therapy Response

Year:
2018
File:
PDF, 15.23 MB
2018
7

Trial Participation Influences Risk of Relapse in AYA Leukemia

Year:
2018
File:
PDF, 15.29 MB
2018
8

Ivosidenib (Tibsovo®)

Year:
2018
File:
PDF, 15.22 MB
2018
10

The Impact of CAR T-Cell Therapy in B-Cell Malignancies

Year:
2018
File:
PDF, 15.46 MB
2018
11

Finding a Less-Invasive Technique for Breast Reconstruction

Year:
2018
File:
PDF, 15.48 MB
2018
12

Promising Results for Entrectinib Against ROS1-Positive NSCLC

Year:
2018
File:
PDF, 15.36 MB
2018
13

Treatment Resistance in EGFR-Mutant NSCLC & Acquired RET Fusion

Year:
2018
File:
PDF, 15.28 MB
2018
14

Matching Patients With the Right Therapy for Their Ovarian Cancer

Year:
2018
File:
PDF, 15.36 MB
2018
15

Silicone Breast Implants Associated With Rare Diseases

Year:
2018
File:
PDF, 15.17 MB
2018
16

Two Studies Focus on the Opioid Use in Oncology

Year:
2018
File:
PDF, 15.22 MB
2018
17

Beautiful Crutches

Year:
2018
File:
PDF, 15.28 MB
2018
18

Cervical Cancer Screening

Year:
2018
File:
PDF, 15.39 MB
2018
19

Brigatinib Becomes Potential First-Line Option for ALK-Positive NSCLC

Year:
2018
File:
PDF, 15.26 MB
2018
20

Shop Talk

Year:
2018
File:
PDF, 15.58 MB
2018
21

Moments

Year:
2018
File:
PDF, 15.24 MB
2018
22

Report Hails Marked Progress Against Cancer, Issues Call to Action

Year:
2018
Language:
english
File:
PDF, 15.30 MB
english, 2018
23

FDA Updates Impacting Treatment Approaches in Oncology

Year:
2018
File:
PDF, 223 KB
2018
24

UpToDate®

Year:
2018
File:
PDF, 15.19 MB
2018